Latest Breaking News On - Revance therapeutics - Page 10 : comparemela.com

Shareholders in Revance Therapeutics (NASDAQ:RVNC) are in the red if they invested a year ago

The art and science of stock market investing requires a tolerance for losing money on some of the shares you buy. But.

Harrow, Inc. Announces Board of Director Appointments

Harrow announced the appointments of Adrienne Graves, Ph.D., and Lauren Silvernail to the Company?s Board of Directors, effective immediately. Harrow?s Board now consists of six members. Dr. Adrienne.

Revance Therapeutics (NASDAQ:RVNC) Price Target Cut to $10.00

Revance Therapeutics (NASDAQ:RVNC) Price Target Cut to $10.00

Revance Therapeutics (NASDAQ:RVNC – Get Free Report) had its price target decreased by analysts at Barclays from $35.00 to $10.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage currently has an “overweight” rating on the biopharmaceutical company’s stock. Barclays‘s price objective would suggest a potential upside of 68.92% […]

Analysts Set Revance Therapeutics, Inc. (NASDAQ:RVNC) Target Price at $22.00